top of page
Regxia Review
Welcome to the Regxia Review. Your go-to resource for regulatory and quality insights.
Amirtha Kavitharan
Dec 17, 20242 min read
Highlights: CAPRA 2024 Pharmaceutical Symposium - Health Canada Updates
Regxia Inc. recently had the opportunity to exhibit and attend the CAPRA 2024 Pharmaceutical Symposium held in Toronto, Canada. The...
Tharshini Veerasingam
Nov 18, 20242 min read
Are you ready for Health Canada's mandatory XML PMs?
Health Canada releases notice regarding mandatory filing requirements for XML PMs, starting in 2025.
Tharshini Veerasingam
Oct 1, 20242 min read
Update: Health Canada’s Guidance on Drug Submissions for Biologics
Health Canada's updated guidance document combines three CTD guidance documents applicable to conventional biotherapeutic products into one.
Quality Team
Sep 12, 20242 min read
Pharmacovigilance / Drug Safety Defined
Pharmacovigilance activities are necessary to ensure the detection, assessment, understanding and prevention of adverse effects.
bottom of page